Trial intelligence / Profile preview

Tramadol Adjuvant Therapy for COVID-19

NCT04454307Phase 2Unknown

Sponsor
Tanta University
Start
Jul 2020
Primary completion
Aug 2020
Modality
Small Molecules
01

Overview

A Phase 2 trial of tramadol in coronavirus disease 2019 (COVID-19), sponsored by Tanta University. Status: unknown.

02

Drugs

tramadol
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04454307.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04454307.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call